ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE

irpages2.eqs.com/websites/a...

Annovis AnnovisBio gets the nod from US_FDA for their Phase 3 clinical study of Buntanetap (Posiphen) in individuals recently diagnosed with #Parkinsons to proceed; 6 months; double-blind, placebo-controlled; 2 doses; N=450; 1# endpoint=UPDRS II+III OFF

twitter.com/ScienceofPD/sta...

[jeffreyn]

"Buntanetap 10 mg, 20 mg, or placebo capsules, taken orally once a day for 6 months"

"in 100 sites in the US and EU"

"start recruiting for the US clinical trial soon, expected later this summer"

With 100 sites, it shouldn't take them too long to get 450 PwPs.

[WinnieThePoo in reply to jeffreyn]

Golly - I do like news like this. Keep 'em coming

[redhawk1]

Hoping 3’s the charm!!!

[Boscoejean]

I wish they would list the locations when they list the clinical trialclinicaltrials.gov/ct2/show...

[jeffreyn in reply to Boscoejean]

They will list them when they start recruitment.

[Farooqji]

Is this symptomatic treatment or disease modifying

[jeffreyn in reply to Farooqji]

They are aiming for "disease modifying".

[jocelyng in reply to jeffreyn]

Aren’t we all!

[jeffreyn]

Some background information on Buntanetap/ANVS401/Posiphen.

healthunlocked.com/cure-par...

[PDWarrior1900]

THANK YOU for posting this! Very encouraging stage 3 trial about to begin...

[Hidden]

youtube.com/watch?v=tiEy6nv...(Not working as expected?)

[jeffreyn]

PNT article: FDA Gives Green Light to Phase 3 Trial of Buntanetap.parkinsonsnewstoday.com/new...